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Sanitation, and Hygiene Trials
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Abstract. Most health impact trials of water, sanitation, and hygiene use caregiver-reported diarrhea in children as the
primary outcome; this measure is known to be subject to considerable bias, especially when used in unblinded trials.
Detection of enteric pathogens in stool or fecal waste viamultiplexmolecularmethodsmayoffer advantages over—and is
complementary to—diarrhea because thesemeasures are objective, on the causal pathway from exposures of interest to
disease outcomes, and increasingly feasible in high-burden countries.
Water, sanitation, and hygiene (WASH) health impact trials
have typically used caregiver-reported childhood diarrhea as a
primary outcome. This is justiﬁed in public health terms as
childhood diarrhea is assumed to account for most of the
WASH-attributable disease burden.1 As a primary outcome for
health impact trials, however, diarrhea is problematic as it
generally relies on self-reported information, with signiﬁcant
potential for bias, especially when used in unblinded trials.2
Beyond these long-standing concerns, important new studies
have demonstrated that the etiology of childhood diarrhea in
high-burden settings is diverse and varies signiﬁcantly by set-
ting, population, and age3;moreover, prevalence and detection
of a range of enteric pathogen targets is very high in at-risk
populations, even in apparently asymptomatic individuals.4
Here, we consider stool-based enteric pathogen detection as
an alternative, novel outcome for WASH trials, offering several
advantages over caregiver-reported diarrhea symptomology.
First, detection of enteric pathogens in stool is an objective
outcome measurable in either quantal or quantitative multiplex
assays and may include viruses, bacteria, protozoa, and hel-
minths of interest. Such methods are supported by standard,
validated procedures used in diagnostic assays, based on well-
characterized gene targets, offering low detection limits and
potential for quantiﬁcation.5,6 A range of commercially available
kits and customassays6–8 have enabled simultaneous detection
of multiple enteric pathogens via molecular methods, many
supported by systematic studies reporting sensitivity and spec-
iﬁcity, compared with alternative methods in different pop-
ulations. These are powerful tools widely available for use
globally; the required molecular facilities are available in most
countries, including thosewithahighburdenofdiarrhealdisease.
Second, stool-based enteric pathogen detection can
identify etiologies of potential importance in populations of
interest; such information may assist with developing more
effective interventions to reduceexposure. Even in siteswhere
information on the diarrheal disease burden is available,
knowledge of potential underlying etiologies of enteric in-
fection and disease remains critically important for the design
of interventions to interrupt transmission. Dominant trans-
mission pathways vary by setting and also by pathogen;
effective interventions to control rotavirus infection in the
United States will differ from those for cryptosporidiosis in
Kenya.
Third, for an individual, detection of an enteric pathogen in
stool is an unambiguous indication of past exposure to that
pathogen. Regardless of symptomology and without indicating
colonization or potential for current or future effects on gut
health, the presence of a pathogen in stool is possible only if the
individual has been exposed at somepoint before the specimen
was collected. As WASH interventions are intended to reduce
exposure to enteric pathogens, the use of straightforward ex-
posure measures as proximal trial outcomes is justiﬁable. En-
tericpathogenpresence in thegut isanecessarypreconditionof
enteric infection, itself on the causal pathway from primary
WASH-related or fecal–oral exposure toWASH-related disease
outcomes, notably diarrheal diseases,3 and various hypothe-
sized sequelae, including environmental enteric dysfunction,9
adverse growth10 and cognitive impairment,11 impacts on the
immune system,12 and poor oral vaccine performance.13
Despite some clear advantages, there are important limita-
tions to stool-based enteric pathogen detection as an outcome
measure in trials. Thescience in thisarea isevolving rapidly, and
our understanding of the many underlying biological mecha-
nisms is incomplete, particularly with respect to the health
signiﬁcance to an individual—if any—of shedding pathogens in
stool when no symptoms are present.8 Pathogen detection in
stool may not necessarily indicate an active infection and may
not have clear implications for gut health. Although subclinical
carriage has been found to be generally high in at-risk
populations,3,4 enteric pathogens may act more as commen-
sal members of the gut microbiota under some conditions.
Enteric pathogen detection may also be inconsistent or
ephemeral in stool based on standard diagnostic assays, and
persistence of infections may vary according to a range of
factors. Entericpathogensheddingmaynot be very sensitive to
changes in exposure over the relatively short time scales of
impact trials; however, more work is needed on asymptomatic
shedding of important enteric pathogens in longitudinal cohort
studies to provide more evidence on this point. Most methods
now under consideration for multiplex pathogen detection in
stool are library-dependent, and therefore, detection will be
limited to speciﬁc targets sought, potentially missing clinically
relevant pathogens. Commercially available platforms for
identiﬁcation of enteric pathogens in stool may also lack
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essential transparency in methods, including full reporting of
primers and probes that would allow for direct comparison
across methods. Metagenomics may offer greater scope for
detection of multiple targets, but will generally have a sub-
stantially higher limit of detection, lowering sensitivity for indi-
vidual pathogens of interest, and may be less available in
settings where risk is highest. Finally, bulk stool or rectal swab
samples may be logistically difﬁcult and, therefore, costly to
obtain in large trials, limiting the use of such measures in
practice. Using aggregate fecal waste streams, such as fecal
sludges or wastewaters,14,15 may offer logistical advantages
over collection of fecal specimens from individuals; however,
this strategy is accompanied by other complications such as
pathogen proliferation (for bacteria) and die-off, potentially
masking important differences in shedding among individuals,
and nonhuman sources. Wastewater monitoring is a common
surveillance method supporting, for example, poliovirus eradi-
cation programs, but may also be more widely applied among
other enteric targets. Whether pathogen detection in environ-
mentalmatricescanprovideausefulproxyoutcomemeasure in
trials remains to be seen; more research is required to un-
derstand whether and to what extent such signals may be
sensitive to changes in disease prevalence or incidence at
various scales.
Stool-based enteric pathogen detection offers several
advantages over the conventional WASH trial outcome of
caregiver-reported diarrhea. Ultimately, without more objec-
tive outcomes relating to speciﬁc diarrheal etiologies, rather
than generalized and subjective symptoms, it will remain
challenging to mobilize the most appropriate interventions,
whether these be environmental, such as WASH, or medical,
such as vaccination.
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